Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone.
AIMS: Epidermal growth factor receptor (EGFR) is implicated in bone remodelling. The aim was to determine whether EGFR protein expression contributes to the aggressiveness and recurrence potential of giant cell tumour of bone (GCTB), an osteolytic primary bone tumour that can exhibit markedly varia...
Main Authors: | Balla, P, Moskovszky, L, Sapi, Z, Forsyth, R, Knowles, H, Athanasou, N, Szendroi, M, Kopper, L, Rajnai, H, Pinter, F, Petak, I, Benassi, MS, Picci, P, Conti, A, Krenacs, T |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2011
|
Similar Items
-
Centrosome abnormalities in giant cell tumour of bone: possible association with chromosomal instability.
by: Moskovszky, L, et al.
Published: (2010) -
Cell Biology of Giant Cell Tumour of Bone: Crosstalk between m/wt Nucleosome H3.3, Telomeres and Osteoclastogenesis
by: Ramses G. Forsyth, et al.
Published: (2021-10-01) -
Ewing sarcoma cells express RANKL and support osteoclastogenesis.
by: Taylor, R, et al.
Published: (2011) -
Ewing sarcoma cells express RANKL and support osteoclastogenesis
by: Taylor, R, et al.
Published: (2011) -
Prognostic impact of reduced connexin43 expression and gap junction coupling of neoplastic stromal cells in giant cell tumor of bone.
by: Peter Balla, et al.
Published: (2015-01-01)